Latest stories on OKYO
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
GlobeNewswire63 · neutralproduct/pr
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
StockTitan56 · neutralproduct/pr
OKYO Pharma to Highlight Urcosimod Progress at Cantor Global Healthcare Conference
TipRanks56 · neutralproduct/pr
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
GlobeNewswire56 · neutralgeneral
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
StockTitan56 · neutralgeneral
Okyo Pharma management to meet virtually with Piper Sandler
The Fly55 · neutralgeneral
OKYO Pharma CSO Increases Stake Ahead of Planned Phase 3 Trial
TipRanks63 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
StockTitan59 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
Business Insider59 · neutralgeneral
OKYO Pharma to Present Late-Stage Ophthalmic Pipeline at BTIG Biotechnology Conference 2026
TipRanks56 · neutralproduct/pr
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
StockTitan56 · neutralgeneral
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
Business Insider56 · neutralgeneral
OKYO Pharma Director Ups Stake Ahead of Planned Phase 3 Neuropathic Corneal Pain Trial
TipRanks58 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Director
StockTitan54 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Director
Business Insider55 · neutralgeneral
OKYO Pharma CEO Boosts Stake With Nasdaq Share Purchase
TipRanks58 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
StockTitan56 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chairman
Business Insider59 · neutralgeneral
OKYO Pharma Executive Boosts Shareholding Ahead of Planned Phase 3 NCP Trial
TipRanks58 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director
StockTitan59 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer
StockTitan56 · neutralgeneral
OKYO Pharma to Present Ophthalmology Pipeline Ahead of Phase 3 Urcosimod Trial
TipRanks56 · neutralproduct/pr
OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
StockTitan56 · neutralproduct/pr
OKYO Pharma chairman increases stake with share purchase
Seeking Alpha58 · neutralgeneral
OKYO Pharma Chairman Boosts Stake Ahead of Phase 3 Neuropathic Corneal Pain Trial
TipRanks63 · neutralproduct/pr